@article{29ae566b310048198fd55d331c6af794,
title = "Performance evaluation of culture-independent sybr green candida auris quantitative PCR diagnostics on anterior nares surveillance swabs",
keywords = "Candida auris, Diagnostics, SYBR",
author = "Ourania Georgacopoulos and Nunnally, \{Natalie S.\} and Ngoc Le and Colleen Lysen and Welsh, \{Rory M.\} and Milena Kordalewska and Perlin, \{David S.\} and Berkow, \{Elizabeth L.\} and \{Joseph Sexton\}, D.",
note = "Funding Information: D.S.P. receives funding from the U.S. National Institutes of Health and contracts with The Centers for Disease Control and Prevention, Amplyx, Astellas, Cidara, and Scynexis. He serves on advisory boards for Amplyx, Astellas, Cidara, Matinas, N8 Medical and Scynexis. In addition, D.S.P. has an issued U.S. patent concerning echinocandin resistance. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",
year = "2020",
month = sep,
doi = "10.1128/JCM.00690-20",
language = "English (US)",
volume = "58",
journal = "Journal of clinical microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "9",
}